|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Argatroban#Adult Indications and Dosage]] |
| {{Argatroban}}
| |
| {{CMG}}; {{AE}} {{JH}}
| |
| | |
| ==Indications and Usage==
| |
|
| |
| ====1.1 Heparin Induced Thrombocytopenia====
| |
| | |
| Argatroban Injection is indicated for prophylaxis or treatment of [[thrombosis]] in adult patients with heparin-induced [[thrombocytopenia]] (HIT).
| |
| | |
| ====1.2 Percutaneous Coronary Intervention====
| |
| | |
| Argatroban Injection is indicated as an anticoagulant in adult patients with or at risk for HIT undergoing [[percutaneous coronary intervention]] (PCI).<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ARGATROBAN INJECTION, SOLUTION [GLAXOSMITHKLINE LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9c9616c0-a299-4fd5-c8ae-79e6db453595 | publisher = | date = | accessdate = }}</ref>
| |
| | |
| ==Reference==
| |
| | |
| {{reflist}}
| |
| | |
| {{FDA}}
| |
| | |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Hematology]]
| |
| [[Category:Drugs]]
| |